Table IV. Number of animals per group for in vivo studies.
| Group | Time of Sacrifice | Plane of Section Cut/Purpose | N | Exclusions |
|---|---|---|---|---|
| αC1q Ab + αC3a Ab + hNSC | 12 wk posttransplant | Transverse/Fate and lesion quantification | 7 | n = 1 was excluded in fate quantification due to poor immunostaining |
| αC1q Ab + αC3a Ab + hNSC | 12 wk posttransplant | Parasagittal/Histology | 2 | None |
| αC1q Ab + αC3a Ab + hNSC | 6 wk posttransplant | Parasagittal/Histology | 2 | None |
| Vehicle + hNSC | 12 wk posttransplant | Transverse/Fate and lesion quantification | 5 | None |
| Vehicle + hNSC | 6 wk posttransplant | Parasagittal/Histology | 5 | None |
| Vehicle + hNSC | 12 wk posttransplant | Parasagittal/Histology | 2 | None |